We are live on ! Find out more
NTBL

Notable Labs, Ltd. Ordinary Shares

Delisted

NTBL was delisted on the 22nd of October, 2024.

18 hedge funds and large institutions have $137K invested in Notable Labs, Ltd. Ordinary Shares in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% less funds holding

Funds holding: 2818 (-10)

53% less capital invested

Capital invested by funds: $295K → $137K (-$158K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 9

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 7

Holders
18
Holders Change
-10
Holders Change %
-35.71%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
7
Closed
9
Calls
Puts
Net Calls
Net Calls Change

NTBL Hedge Fund Activity: Q1 2023 in Review

18 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Notable Labs, Ltd. Ordinary Shares (NTBL) for Q1 2023, worth a combined $137K — down 53% from $295K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of NTBL and 0 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 0 added.

The largest seller was Acadian Asset Management, exiting entirely with an estimated $33K sold.

  • 18 institutional investors held Notable Labs, Ltd. Ordinary Shares (NTBL) as of Q1 2023, down from 28 in Q4 2022.
  • Funds reported $137K of Notable Labs, Ltd. Ordinary Shares stock for Q1 2023, down 53% quarter-over-quarter.
  • 0 funds opened new Notable Labs, Ltd. Ordinary Shares positions in Q1 2023 and 9 closed out, a net change of -9 holders.
  • The largest Notable Labs, Ltd. Ordinary Shares seller in Q1 2023 was Acadian Asset Management, an estimated $33K sold.

Based on aggregated 13F filings for Q1 2023.